HER2-Low and Ultra-Low expression in young women with luminal breast cancer in Mexico

被引:0
|
作者
Hernandez, Jesus Edgardo Hernandez
Torres, Cesar Octavio Lara
Moran, Bryan Moreno
Garza, Cynthia Villareal
Reyes, Fany Iris Porras
Sanchez, Victor Manuel Perez
Mohar, Alejandro
机构
关键词
D O I
10.1158/1538-7445.SABCS23-PO4-25-09
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PO4-25-09
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Sensitivity analysis of different HER2 clone numbers for detecting HER2 low and ultra-low expression in invasive breast cancer
    Liu, Y.
    Shang, J.
    He, J.
    Ding, Y.
    Li, J.
    VIRCHOWS ARCHIV, 2024, 485 : S197 - S198
  • [32] The " lows " : Update on ER-low and HER2-low breast cancer
    Fusco, Nicola
    Viale, Giuseppe
    BREAST, 2024, 78
  • [33] Clinical outcomes in women with metastatic HER2-Low breast cancer in the real world
    Jiang, Changchuan
    Perimbeti, Stuthi
    Deng, Lei
    Shapiro, Charles L.
    Gandhi, Shipra
    CANCER RESEARCH, 2022, 82 (12)
  • [34] Genomic and Transcriptomic Landscape of HER2-Low Breast Cancer
    Bansal, Rani
    McGrath, Julie
    Walker, Phil
    Bustos, Matias A.
    Rodriguez, Estelamari
    Sammons, Sarah L.
    Accordino, Melissa K.
    Meisel, Jane
    Gatti-Mays, Margaret
    Hsu, Emily
    Lathrop, Kate I.
    Kaklamani, Virginia
    Oberley, Matthew
    Korn, W. Michael
    Graff, Stephanie L.
    CANCER RESEARCH, 2023, 83 (05)
  • [35] Comprehensive genomic characterization of HER2-low breast cancer
    Tarantino, Paolo
    Gupta, Hersh V.
    Hughes, Melissa E.
    Files, Janet L.
    Strauss, Sarah
    Kirkner, Gregory
    Feeney, Anne-Marie
    Li, Yvonne Y.
    Garrido-Castro, Ana C.
    Barroso-Sousa, Romualdo
    Bychkovsky, Brittany
    MacConaill, Laura
    Lindeman, Neal
    Johnson, Bruce
    Meyerson, Matthew
    Kabraji, Sheheryar
    Jeselsohn, Rinath
    Qiu, Xintao
    Li, Rong
    Long, Henry W.
    Winer, Eric
    Dillon, Deborah A.
    Curigliano, Giuseppe
    Cherniack, Andrew
    Tolaney, Sara
    Lin, Nancy U.
    CANCER RESEARCH, 2023, 83 (05)
  • [36] Frequency of HER2-Low in breast cancer biopsies in Chile
    Vidal, Martin
    Rivera, Alvaro
    Schuler, Constanza
    Garnham, Nicolas
    Alcalde, Elisa
    Renner, Alex
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] TRASTUZUMAB DERUXTECAN IS EFFECTIVE IN HER2-LOW BREAST CANCER
    不详
    CANCER DISCOVERY, 2020, 10 (04) : 488 - 488
  • [38] HER2-low breast cancer: insights on pathological testing
    Liu, Yueping
    TRANSLATIONAL BREAST CANCER RESEARCH, 2023, 4
  • [39] HER2-Low Breast Cancer: Pathological and Clinical Landscape
    Tarantino, Paolo
    Hamilton, Erika
    Tolaney, Sara M.
    Cortes, Javier
    Morganti, Stefania
    Ferraro, Emanuela
    Marra, Antonio
    Viale, Giulia
    Trapani, Dario
    Cardoso, Fatima
    Penault-Llorca, Frederique
    Viale, Giuseppe
    Andre, Fabrice
    Curigliano, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (17) : 1951 - +
  • [40] A comparison between immunohistochemistry and mRNA expression to detect HER2-low breast cancer
    Navarro, X. Baez
    van Bockstal, M. R.
    van der Made, A.
    van Deurzen, C. H. M.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 104 - 104